chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a female patient who on an unspecified date was vaccinated with a dose of GARDASIL (lot # not specified), intramuscularly.  The patient experienced muscle pain, weakness and fatigue after receiving the GARDASIL vaccine.  The physician indicated that the patient was planning report the events.  The patient sought unspecified medical attention and underwent unspecified tests by a rheumatologist.  At the time of reporting, the outcome of the event is unknown.  Additional information has been requested.
pericarditis; had severe pain in my chest; I was coughing up an alarming amount of blood; chronic fatigue; shortness of breath; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 26-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Nov2021 at 09:00 as dose 1, single (Lot number: FG3527) at the age of 26 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies :Penicillin" (unspecified if ongoing), notes: Known allergies: Penicillin. The patient's concomitant medications were not reported. The following information was reported: HAEMOPTYSIS (hospitalization, disability) with onset 13Nov2021, outcome "not recovered", described as "I was coughing up an alarming amount of blood"; FATIGUE (hospitalization, disability) with onset 13Nov2021, outcome "not recovered", described as "chronic fatigue"; CHEST PAIN (hospitalization, disability) with onset 13Nov2021, outcome "not recovered", described as "had severe pain in my chest"; PERICARDITIS (hospitalization, disability, medically significant) with onset 13Nov2021, outcome "not recovered"; DYSPNOEA (hospitalization, disability) with onset 13Nov2021, outcome "not recovered", described as "shortness of breath". The patient was hospitalized for pericarditis, chest pain, haemoptysis, fatigue, dyspnoea (hospitalization duration: 1 day(s)). The events "pericarditis", "had severe pain in my chest", "i was coughing up an alarming amount of blood", "chronic fatigue" and "shortness of breath" required physician office visit and emergency room visit. Therapeutic measures were taken as a result of pericarditis, chest pain, haemoptysis, fatigue, dyspnoea. Clinical curse: In less than 24 hours the patient began experiencing symptoms from first dose of the Pfzier vaccine. The patient was coughing up an alarming amount of blood and had severe pain in chest. A Doctor at urgent care informed patient body was reacting to the vaccine and to give it a few days. As the problem persisted, patient was hospitalized. As a result of the vaccine, patient have experienced chronic fatigue, stabbing chest pain, and shortness of breath. The patient had spent the past year struggling with this, in and out of doctor's offices, and was diagnosed with pericarditis. Prior to this, patient was a perfectly healthy 26-year-old with none of these ailments. The vaccine has been detrimental to my health and quality of life. Ae treatment was reported as EKG, bloodwork, etc. The patient had no COVID prior vaccination. It was unknown if COVID tested post vaccination. The patient had no other vaccine in four week.
Sudden onset unresponsiveness 5 hours after vaccinations with persistent abnormal mental status.  12/23/2008 MR received for DOS 12/2-4/2008 with DX:  ALTE. Pt presented after an episode of unresponsiveness and pallor. Pt's eyes rolled back and pt was clammy and "out of it".  Responsive only to pain. Still with altered mental status/LOC in ER, somewhat improved with IVF.  Admitted for sepsis w/u. Dx with GERD.
Decrease in his energy levels; Feeling dizzy; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Decrease in his energy levels) and DIZZINESS (Feeling dizzy) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced ASTHENIA (Decrease in his energy levels) and DIZZINESS (Feeling dizzy). On 16-Feb-2021, ASTHENIA (Decrease in his energy levels) and DIZZINESS (Feeling dizzy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
This spontaneous report as received from a registered nurse refers to about 7-8 patients of unknown age and gender. On an unknown date, the patients were vaccinated with a 0.5 ml doses of VARIVAX (Merck) (Lot # J008659, expiration date 10-JUL-2015) SQ that underwent a temperature excursion. No adverse effect was reported. Additional information has been requested.
Left arm- Pt received DTaP on 04/18/05- Pt mom called 04/21/2005 stating pt had bruising on left arm. Pt seen 04/21/05- mild erythema, with ecchymosis above shot administration area.
On December 16, 2022, my symptoms were a fever and a pretty good sinus, head and chest cold. I began taking PAXLOVID Tuesday, December 20, 2022. I began to feel better the next day.
A week after the initial vaccination I developed a red, itchy rash on and about the injection site. It was about 2" in diameter. The following day the rash area felt very hard and thick to the touch. The hardness subsided that evening but was replaced by heat. I began to ice the area a couple times a day. That Sunday a large oval, red "ring" appeared on my upper arm. The shape was distorted and was the color of a new sunburn. The heat dissipated after a few days but the rash and outside ring are still visible after 5 days.
Information has been received from a physician concerning a 9 month, 6 day old male with food allergies, eczema and a sulfa allergy who on 9/14/05 was vaccinated with a first 0.5ml dose of RECOMBIVAX HB (lot # 650952/0145R). Concomitant therapy included loratadine. The patient's mother called the physician 2 hours after the vaccination, on 9/14/05, and reported that the child stiffened, turned red and vomited. The physician was admitting the infant to the hospital for observation. It was reported that the patient was recovering. There were no laboratory or diagnostic tests performed. No product quality complaint was involved. No other information was provided. The reporter considered the experience to be an other important medical event (OMIC). Additional information has been requested.
One of their employees administered a full dose of the vaccine without reconstituting the medication; One of their employees administered a full dose of the vaccine without reconstituting the medication; This is a spontaneous report from a contactable Other Health Care Professional. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date, as unknown, single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. On 15Jun2021, reporter stated that this morning one of their employees administered a full dose of the vaccine without reconstituting the medication, reporter has reported it and filed a report, now asking for guidance recommendations. The outcome of events was unknown.  Information on the Lot/Batch number has been requested.; Sender's Comments: Based on the information provided in the narrative, the causal association between the suspect drug and the events cannot be excluded.
12:05 States that she cannot move her right arm which is the arm she received the injection. States she is being worked up for MS but is concerned about current disease symptomology causing these effects. Not having emergent crisis such as an anaphylactic reaction. 12:10 observed entire right arm shaking uncontrollably and she stated she was having a dystonic reaction. Took her back to the emergency area and she asked me to call her husband in which I did and left a message 12:12 Asked her to remove her mask so she could take deep breaths and noticed her left side of her face was drooping.  ED was called. 12:20 Emergency services arrived  12:35 Pt transported via ambulance to local hospital
delayed injection site reaction :  reddish, elevated rash, itching , discomfort as if another shot had been given, measured 1- 1/2 inches by 2- 3/4 inches and it has stayed the same size.  Woke up with it on 1/11, the 9th day after injection.  Today is 1/14 and it is improving, but still present, less red, less painful, less itchy. Used a small amount of topical Betamethasone on 1/11 and 1/12.
Arm sore; Headache; Pregnant patient received flu vaccine; This spontaneous case was received on 29-Oct-2020 from other non-health professional via Med Communication (reference number: SEQW20-04493) and concerned a 42-year-old, pregnant female patient.  The patient's relevant medical history included unspecified contraceptive, used for in vitro process (used with other pills). The patient's concomitant medications were low doses of ibuprofen and Prenatal DHA (docosahexaenoic acid), both used for unreported indications.  The patient's obstetrical history included two previous pregnancies, one successful and one miscarriage. The estimated delivery date was reported as 29-Jan-2021.  On 28-Oct-2020, the patient was vaccinated with Flucelvax QIV (influenza vaccine, subunit influenza virus vaccine polyvalent; route of administration: intramuscular, dose: 0.5 ml and anatomical location: not reported) (explicitly coded as 'Vaccine exposure during pregnancy') for influenza prophylaxis. The batch number was not reported.  On the same day, after received Flucelvax QIV vaccine, the patient experienced sore arm and headache.  The outcome of the events sore arm and headache was unknown.  The reporter did not provide a causality assessment to Flucelvax QIV.  The reporter assessed the events as non-serious.  Company comment: A 42-year-old, pregnant patient was vaccinated with Flucelvax QIV. On the same day, after receiving vaccine, the patient experienced pain in extremity and headache. Causal role of the suspect vaccine is assessed as possibly related, considering plausible temporal relationship.  Vaccine exposure during pregnancy is assessed as not related, per company's conventions.; Sender's Comments: A 42-year-old, pregnant patient was vaccinated with Flucelvax QIV. On the same day, after receiving vaccine, the patient experienced pain in extremity and headache. Causal role of the suspect vaccine is assessed as possibly related, considering plausible temporal relationship.  Vaccine exposure during pregnancy is assessed as not related, per company's conventions.
Information has been received from a health professional concerning a 65 year old white female with no pertinent medical history or drug reactions/allergies who on 15-OCT-2007 was vaccinated with pneumococcal 23v polysaccharide vaccine (lot 657626/1084U) IM in the right deltoid. Concomitant therapy on the same day included influenza virus vaccine (unspecified). On 17-OCT-2007, the patient called the office at 2:53PM and complained of dizziness, headache behind eye, fever was 101.2, right arm was swollen and hot to touch. The patient had asked to get a flu shot and pneumococcal 23v polysaccharide vaccine in the same arm on 15-OCT-2007. Diagnosis was right arm cellulitis and allergic reaction. The treatment included KEFLEX 500mg BID for 10 days, BENADRYL 25 mg at bedtime and ibuprofen HCl 200mg TID when needed. Both sites were involved. Erythematous patches. Temperature was 99.5. At the time of reporting the patient had recovered. Additional information is not expected.
Bell's Palsy; her face felt numb; tingling and pain on her left ear; tingling and pain on her left ear; This is a spontaneous report from a contactable consumer.    A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 08Mar2021  as single dose for Covid-19 immunisation  .  The patient medical history and  concomitant medications were not reported.  The patient experienced bell's palsy  on 08Mar2021 with outcome of unknown. On her way home the patient  face felt numb  , tingling and pain on her left ear The reported events were considered Important Medical Events. The patient is wondering if the Company has been informed about Bell's palsy.  Information about batch/lot number has been requested.
9:00 am arm sore, temperature 99.7 Took two ibuprofen (200 mg each) 4:00 pm chills 7:00 pm  temperature 100.7, took two ibuprofen (200 mg each)
No adverse effect to patient.  Vial had expired in the middle of the night, was dated the next day and staff thought it could be used as it was dated same day.  Contacted clinic personnel and were informed Pfizer has a 12 hour window after time expiration.  No adverse effect to patient.
severe pain in my forearm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (severe pain in my forearm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (severe pain in my forearm). At the time of the report, PAIN IN EXTREMITY (severe pain in my forearm) outcome was unknown.            No concomitant medication was reported. No treatment medication was reported.
Pt complained of chest congestion and chest pain.  She said it wasn't a big deal today (4/19/22) as she had "almost worked it all out."  She was specifically talking about chest mucus/congestion.  She said she didn't have a fever and there was no other pain in other parts of the body.   She was taking ibuprofen to control the pain.
Fever of 102.9 started on 9/19/18; Bruising and redness at injection site (Left thigh); Still having fever of 102.4 as of 9/20/18.
Pt felt faint after receiving flu vaccine. She was given cool towels, beverage twist up, pulse 86, resp. 18, was alert and oriented x person, place, situation, reports that she done this before 4 years ago while driving.
Information has been received from a physician concerning a 67 year old male who was vaccinated with a dose of Zostavax. Shortly after receiving the injection, the patient developed a rash that looked like poison ivy near injection site. Subsequently, the patient recovered. The patient sought unspecified medical attention. There was no product quality complaint. Additional information has been requested.
24 hrs after injection fever, malaise, myalgia, burning sensation in chest, airway swelling and cough non productive, dry, visual disturbance with white strobe light left eye, no sore throat, weakness.
Information has been received as part of a class action suit concerning a pregnant female who was vaccinated with hepatitis B immune globulin. Subsequently, the patient's son experienced neurological disorder and mercury poisoning. Upon internal review, neurological disorder and mercury poisoning were considered other important medical events (OMIC). No further information is available. This report was received from the manufacturer's legal department on 12/13/04.
reaction to excipient; kidneys tried to shut down; This is a spontaneous report from a contactable consumer from a Pfizer Sponsored Program.  A female patient of an unspecified age received the bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), and potassium (MANUFACTURER UNKNOWN); both via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunisation. The patient's medical history included ongoing kidney issues from an unknown date, allergic to antibiotics and pain pills from an unknown date and unknown if ongoing. Concomitant medications were not reported. On an unspecified date, the patient experienced: kidneys tried to shut down and reaction to excipient; which were assessed as medically significant. The consumer stated, "I looked at the ingredient list: potassium is listed. I have kidney issues and potassium is really bad, my kidneys tried to shut down on me. I'm allergic to "antibiotics and pain pills." The clinical outcome of the events, renal failure and reaction to excipient, was unknown.  The batch/lot numbers for the vaccine, PFIZER-BIONTECH COVID-19 MRNA VACCINE, were not provided and will be requested during follow up.
14x18 cm warm, red skin over right upper arm injection site centrally positioned; 1x3 cm induration around injection site. Not tender. No fever.
5 days after patient received 1st dose of vaccine, a red rash started on patient's back. By noon the rash moved to patient's arms. Throughout the day rash went to thighs and backs of legs, stopped at ankles. Patient went to  ER at 10:45pm on 3/2/2021. Patient was given Prednisone 10mg twice daily for 5 days.
Heaviness in left arm/chest. Numbness in fingers. Soreness at site area.
1.) 9/22/21 - IM injection to R upper arm in am, taken to daycare after appt & noted about "a quarter" size Redness & area warm; by 6pm redness was size of pt palm/warm & sore; used cool compress; 0 fever 2.) 9/23/21 - increased Redness from shoulder to elbow; increase swelling, used warm compress; 0 fever 3.) - f/u appt in office, decreased redness, increased pain/swelling to upper arm
Dizziness/lapse in memory on two separate occasions. First occasion while driving, abruptly stopped speaking in middle of sentence and forgot roughly 5 minutes of drive home from work (pt is an RN). Second occasion while in shower, lapse in memory lasted roughly 1-2 minutes.
Severe swelling and pain at the injection site.  Hurt to move the arm.  Reaction was delayed and happened almost a week later.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. No information on concurrent conditions and medical history was reported. Approximately in 2015 (between 24-JUL-2015 to 10-AUG-2015), the patients were vaccinated with 5 doses of improperly stored (Oka/Merck) VARIVAX (unknown route, strength and dose) (L010144 with expiry date of 24-MAR-2017, Lot # L001335 with expiry date of 13-JAN-2017, lot # L008272 with expiry date of 11-MAR-2017). Concomitant medications were not reported. No adverse effects were reported. There was no product quality complaint involved. Additional information has been requested.
Seven days after the first shot of the Moderna covid vaccine the patient experienced itching and redness at the injection site. Her left shoulder is swollen, painful and red. The redness is 3 inches around and hot to the touch. Temperature of red area is 101 degrees Fahrenheit. She is not experiencing a fever overall, temporal temperature is 97.8 F
A week after I went to the ER for chest pain. I thought it was Asthma, but they did an extra and my heart has enlarge. I also have an ovarian cyst.
Resident was admitted to Hospital on 12/26/2021 and returned to facility on 12/28/2021 with a diagnosis of Pneumonia due to COVID.  On 01/08/2022 Physical Therapy asked nursing to assess her and they could not find a blood pressure. MD was notified and orders to send to the emergency room and resident expired before they sent her out. She was a DNR.
SUSPECTED CLINICAL VACCINATION FAILURE; COUGHING BAD; PAIN IN JOINTS/HORRIBLE LEG JOINT PAIN; HEADACHE; COVID-19; This spontaneous report received from a patient via a company representative concerned a patient of an unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry: unknown) dose was not reported, 1 total administered on AUG-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  After patient received vaccine, developed side effects such as pain in joints not horrible but noticeable, headache bad not horrible and cough. On 22-OCT-2021, patient experienced covid (suspected clinical vaccination failure). It was reported that later, patient had horrible leg joint pain (reported as "worst pain ever had in life about 4 full days"), developed bad headache again and bad cough that the patient thought the ribs were broken. After two weeks the patient only had cough. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from covid-19, pain in joints/horrible leg joint pain, and headache, had not recovered from coughing bad, and the outcome of suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with regulatory authority: 90000202280.; Sender's Comments: V0: 20211133931-COVID-19 VACCINE AD26.COV2.S-Suspected clinical vaccine failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS.
patient received moderna covid-19 vaccines on 1/22/2021 and 2/24/2021. he presented to the ED on 2/26/21 with fall and shortness of breath. patient had been generally weak and having difficulty ambulating for some time and was worse the last 2-3 days. patient fell in the evening and could not get back up due to weakness. he was found the following morning and EMS was called. patient was brought to the ED. he was admitted for acute respiratory failure with hypoxia, COPD, pneumonia, NSTEMI, and rhabdomyolysis. also treated for type 2 DM, HTN, and paroxysmal atrial fibrillation. some concern that covid-19 vaccine may have contributed to the patient's rhabdomyolysis. per physician note on 3/3/2021: "Covid 19 infection November 2020, got vaccinated in mid January and then again in February and got a bad reaction which was somewhat to be expected to lead to more marked myalgias and muscle weakness left him lying on the floor unable to get up and he developed rhabdomyolysis." patient is still currently admitted, though CK levels have improved.
1 week after 2nd Anthrax shot: Severe swelling of left wrist, aches in right shoulder and lower back.  Nose swollen and painful to the touch.
Died; got Guilaine Barre Syndrome; This serious case was reported by a consumer via interactive digital media and described the occurrence of unknown cause of death in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced unknown cause of death (Verbatim: Died) (serious criteria death and GSK medically significant) and guillain barre syndrome (Verbatim: got Guilaine Barre Syndrome) (serious criteria GSK medically significant). The outcome of the guillain barre syndrome was not reported. The reported cause of death was unknown cause of death.  It was unknown if the reporter considered the unknown cause of death and guillain barre syndrome to be related to Shingles vaccine.  It was unknown if the company considered the unknown cause of death and guillain barre syndrome to be related to Shingles vaccine.  Additional Information: GSK Receipt Date: 01-APR-2023 This case was reported by the patient's child friend via interactive digital media.  The reporter stated that the patient got that vaccine and got Guillain Barr Syndrome and died. The reporter had asked to do your research properly. Make sure you were willing to take the risks. The reporter had stated that, he/she would not risk it.  Follow-up would not possible as no contact details were available.; Reported Cause(s) of Death: Unknown cause of death